Publications search

Found 37769 matches. Displaying 1131-1140
Valet M, Siggia ED, Brivanlou AH
Show All Authors

Mechanical regulation of early vertebrate embryogenesis

NATURE REVIEWS MOLECULAR CELL BIOLOGY 2022 MAR; 23(3):169-184
Embryonic cells grow in environments that provide a plethora of physical cues, including mechanical forces that shape the development of the entire embryo. Despite their prevalence, the role of these forces in embryonic development and their integration with chemical signals have been mostly neglected, and scrutiny in modern molecular embryology tilted, instead, towards the dissection of molecular pathways involved in cell fate determination and patterning. It is now possible to investigate how mechanical signals induce downstream genetic regulatory networks to regulate key developmental processes in the embryo. Here, we review the insights into mechanical control of early vertebrate development, including the role of forces in tissue patterning and embryonic axis formation. We also highlight recent in vitro approaches using individual embryonic stem cells and self-organizing multicellular models of human embryos, which have been instrumental in expanding our understanding of how mechanics tune cell fate and cellular rearrangements during human embryonic development. Cells in the embryo are subject to autonomous and external mechanical forces that help steer embryonic tissue patterning. Technical developments, such as in vitro models of early embryos, allow probing of the roles of mechanical forces in animal and human embryonic development.
Yang N, Luna J, Dai PH, Wang Y, Rice C, Deng L
Show All Authors

Lung type II alveolar epithelial cells collaborate with CCR2(+) inflammatory monocytes in host defense against poxvirus infection

NATURE COMMUNICATIONS 2022 MAR 29; 13(1):? Article 1671
Smallpox is a highly contagious respiratory pathogen associated with a high mortality rate. Here the authors utilize a mouse model of intranasal vaccinia virus infection and show a C7 gene encoded virulence factor attenuates type I IFN release by lung type II alveolar epithelial cells and reduces lung inflammatory monocyte responses. The pulmonary immune system consists of a network of tissue-resident cells as well as immune cells that are recruited to the lungs during infection and/or inflammation. How these immune components function during an acute poxvirus infection is not well understood. Intranasal infection of mice with vaccinia virus causes lethal pneumonia and systemic dissemination. Here we report that vaccinia C7 is a crucial virulence factor that blocks activation of the transcription factor IRF3. We provide evidence that type II alveolar epithelial cells (AECIIs) respond to pulmonary infection of vaccinia virus by inducing IFN-beta and IFN-stimulated genes via the activation of the MDA5 and STING-mediated nucleic acid-sensing pathways and the type I IFN positive feedback loop. This leads to the recruitment and activation of CCR2(+) inflammatory monocytes in the infected lungs and subsequent differentiation into Lyve1(-) interstitial macrophages (Lyve1(-) IMs), which efficiently engulf viral particles and block viral replication. Our results provide insights into how innate immune sensing of viral infection by lung AECIIs influences the activation and differentiation of CCR2(+) inflammatory monocytes to defend against pulmonary poxvirus infection.
Monelli E, Villacampa P, Zabala-Letona A, Martinez-Romero A, Llena J, Beiroa D, Gouveia L, Chivite I, Zagmutt S, Gama-Perez P, Osorio-Conles O, Muixi L, Martinez-Gonzalez A, Castillo SD, Martin-Martin N, Castel P, Valcarcel-Jimenez L, Garcia-Gonzalez I, Villena JA, Fernandez-Ruiz S, Serra D, Herrero L, Benedito R, Garcia-Roves P, Vidal J, Cohen P, Nogueiras R, Claret M, Carracedo A, Graupera M
Show All Authors

Angiocrine polyamine production regulates adiposity

NATURE METABOLISM 2022 MAR; 4(3):327-+
Reciprocal interactions between endothelial cells (ECs) and adipocytes are fundamental to maintain white adipose tissue (WAT) homeostasis, as illustrated by the activation of angiogenesis upon WAT expansion, a process that is impaired in obesity. However, the molecular mechanisms underlying the crosstalk between ECs and adipocytes remain poorly understood. Here, we show that local production of polyamines in ECs stimulates adipocyte lipolysis and regulates WAT homeostasis in mice. We promote enhanced cell-autonomous angiogenesis by deleting Pten in the murine endothelium. Endothelial Pten loss leads to a WAT-selective phenotype, characterized by reduced body weight and adiposity in pathophysiological conditions. This phenotype stems from enhanced fatty acid beta-oxidation in ECs concomitant with a paracrine lipolytic action on adipocytes, accounting for reduced adiposity. Combined analysis of murine models, isolated ECs and human specimens reveals that WAT lipolysis is mediated by mTORC1-dependent production of polyamines by ECs. Our results indicate that angiocrine metabolic signals are important for WAT homeostasis and organismal metabolism. Endothelial cells in white adipose tissue are shown to produce polyamines, which regulate adipocyte lipolysis, thus demonstrating how local angiocrine signals contribute to healthy adipose tissue homeostasis.
Abt I, Aggarwal R, Andreev V, Arratia M, Aushev V, Baghdasaryan A, Baty A, Begzsuren K, Behnke O, Belousov A, Bertolin A, Bloch I, Boudry V, Brandt G, Brock I, Brook NH, Brugnera R, Bruni A, Buniatyan A, Bussey PJ, Bystritskaya L, Caldwell A, Campbell AJ, Avila KBC, Catterall CD, Cerny K, Chekelian V, Chen Z, Chwastowski J, Ciborowski J, Ciesielski R, Contreras JG, Cooper-Sarkar AM, Corradi M, Mendez LC, Currie J, Cvach J, Dainton JB, Daum K, Dementiev RK, Deshpande A, Diaconu C, Dusini S, Eckerlin G, Egli S, Elsen E, Favart L, Fedotov A, Feltesse J, Ferrando J, Fleischer M, Fomenko A, Foster B, Gal C, Gallo E, Gangadharan D, Garfagnini A, Gayler J, Gehrmann-De Ridder A, Gehrmann T, Geiser A, Gladilin LK, Glover EWN, Goerlich L, Gogitidze N, Golubkov YA, Gouzevitch M, Grab C, Greenshaw T, Grindhammer G, Grzelak G, Gwenlan C, Haidt D, Henderson RCW, Hladky J, Hochman D, Hoffmann D, Horisberger R, Hreus T, Huber F, Huss A, Jacobs PM, Jacquet M, Janssen T, Jomhari NZ, Jung AW, Jung H, Kadenko I, Kapichine M, Karshon U, Katzy J, Kaur P, Kiesling C, Klanner R, Klein M, Klein U, Kleinwort C, Klest HT, Kogler R, Korzhavina IA, Kostka P, Kovalchuk N, Kretzschmar J, Krucker D, Kruger K, Kuze M, Landon MPJ, Lange W, Laycock P, Lee SH, Levchenko BB, Levonian S, Levy A, Li W, Lin J, Lipka K, List B, List J, Lobodzinski B, Lohr B, Lohrmann E, Long OR, Longhin A, Lorkowski F, Lukina OY, Makarenko I, Malinovski E, Malka J, Martyn HU, Masciocchi S, Maxfield SJ, Mehta A, Meyer AB, Meyer J, Mikocki S, Mikuni VM, Mondal MM, Morgan T, Morozov A, Muller K, Nachman B, Nagano K, Nam JD, Naumann T, Newman PR, Niebuhr C, Niehues J, Nowak G, Olsson JE, Onishchuk Y, Ozerov D, Park S, Pascaud C, Patel GD, Paul E, Perez E, Petrukhin A, Picuric I, Pidhurskyi I, Pires J, Pitzl D, Polifka R, Polini A, Preins S, Przybycien M, Quintero A, Rabbertz K, Radescu V, Raicevic N, Ravdandorj T, Reimer P, Rizvi E, Robmann P, Roosen R, Rostovtsev A, Rotaru M, Ruspa M, Sankey DPC, Sauter M, Sauvan E, Schmitt S, Schmookler BA, Schneekloth U, Schoeffel L, Schoening A, Schorner-Sadenius T, Sefkow F, Selyuzhenkov I, Shchedrolosiev M, Shcheglova LM, Shushkevich S, Skillicorn IO, Slominski W, Solano A, Soloviev Y, Sopicki P, South D, Spaskov V, Specka A, Stanco L, Steder M, Stefaniuk N, Stella B, Straumann U, Sun C, Surrow B, Sutton MR, Sykora T, Thompson PD, Tokushuku K, Traynor D, Tseepeldorj B, Tu Z, Turkot O, Tymieniecka T, Valkarova A, Vallee C, Van Mechelen P, Verbytskyi A, Abdullah WATW, Wegener D, Wichmann K, Wing M, Wunsch E, Yamada S, Yamazaki Y, Zacek J, Zarnecki AF, Zenaiev O, Zhang J, Zhang Z, Zlebcik R, Zohrabyan H, Zomer F
Show All Authors

Impact of jet-production data on the next-to-next-to-leading-order determination of HERAPDF2.0 parton distributions

EUROPEAN PHYSICAL JOURNAL C 2022 MAR; 82(3):? Article 243
The HERAPDF2.0 ensemble of parton distribution functions (PDFs) was introduced in 2015. The final stage is presented, a next-to-next-to-leading-order (NNLO) analysis of the HERA data on inclusive deep inelastic ep scattering together with jet data as published by the HI and ZEUS collaborations. A perturbative QCD fit, simultaneously of alpha(s) (M-Z(2)) and the PDFs, was performed with the result alpha(s) (M-Z(2)) (MD = 0.1156 +/- 0.0011 (exp) (-0.0002)(+0.0001) (model +parameterisation) +/- 0.0029 (scale). The PDF sets of HERAPDF2.0Jets NNLO were determined with separate fits using two fixed values of alpha(s) (M-Z(2)), alpha(s) (M-Z(2)) = 0.1155 and 0.118, since the latter value was already chosen for the published HERAPDF2.0 NNLO analysis based on HERA inclusive DIS data only. The different sets of PDFs are presented, evaluated and compared. The consistency of the PDFs determined with and without the jet data demonstrates the consistency of HERA inclusive and jet-production cross-section data. The inclusion of the jet data reduced the uncertainty on the gluon PDF. Predictions based on the PDFs of HERAPDF2.0Jets NNLO give an excellent description of the jetproduction data used as input.
Moya MV, Kim RD, Rao MN, Cotto BA, Pickett SB, Sferrazza CE, Heintz N, Schmidt EF
Show All Authors

Unique molecular features and cellular responses differentiate two populations of motor cortical layer 5b neurons in a preclinical model of ALS

CELL REPORTS 2022 MAR 22; 38(12):? Article 110556
Many neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), lead to the selective degeneration of discrete cell types in the CNS despite the ubiquitous expression of many genes linked to disease. Therapeutic advancement depends on understanding the unique cellular adaptations that underlie pathology of vulnerable cells in the context of disease-causing mutations. Here, we employ bacTRAP molecular profiling to elucidate cell type-specific molecular responses of cortical upper motor neurons in a preclinical ALS model. Using two bacTRAP mouse lines that label distinct vulnerable or resilient projection neuron populations in motor cortex, we show that the regulation of oxidative phosphorylation (Oxphos) pathways is a common response in both cell types. However, differences in the baseline expression of genes involved in Stem and the handling of reactive oxygen species likely lead to the selective degeneration of the vulnerable cells. These results provide a framework to identify cell-type-specific processes in neurodegenerative disease.
Eisner NL, Johnston C, Toonen S, Frost AJ, Janssens S, Lintott CJ, Aigrain S, Sana H, Abdul-Masih M, Arellano-Cordova KZ, Beck PG, Bordier E, Cannon E, Escorza A, Fabry M, Hermansson L, Howell SB, Miller G, Sheyte S, Alhassan S, Baeten EML, Barnet F, Bean SJ, Bernau M, Bundy DM, Di Fraia MZ, Emralino FM, Goodwin BL, Hermes P, Hoffman T, Huten M, Janicek R, Lee S, Mazzucato MT, Rogers DJ, Rout MP, Sejpka J, Tanner C, Terentev IA, Urvoy D
Show All Authors

Planet Hunters TESS IV: a massive, compact hierarchical triple star system TIC 470710327

MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY 2022 MAR 2; 511(4):4710-4723
We report the discovery and analysis of a massive, compact, hierarchical triple system (TIC 470710327) initially identified by citizen scientists in data obtained by NASA's Transiting Exoplanet Survey Satellite (TESS). Spectroscopic follow-up observations obtained with the hermes spectrograph, combined with eclipse-timing variations (ETVs), confirm that the system is comprised of three OB stars, with a compact 1.10 d eclipsing binary and a non-eclipsing tertiary on a 52.04 d orbit. Dynamical modelling of the system (from radial velocity and ETVs) reveal a rare configuration wherein the tertiary star (O9.5-B0.5V; 14-17 M-circle dot) is more massive than the combined mass of the inner binary (10.9-13.2 M-circle dot). Given the high mass of the tertiary, we predict that this system will undergo multiple phases of mass transfer in the future, and likely end up as a double neutron star gravitational wave progenitor or an exotic Thorne-Zytkow object. Further observational characterization of this system promises constraints on both formation scenarios of massive stars as well as their exotic evolutionary end-products.
McCance K, Wise H, Simpson J, Batchelor B, Hale H, McDonald L, Zorzoli A, Furrie E, Chopra C, Muecksch F, Hatziioannou T, Bieniasz PD, Templeton K, Jenks S
Show All Authors

Evaluation of SARS-CoV-2 antibody point of care devices in the laboratory and clinical setting

PLOS ONE 2022 MAR 31; 17(3):? Article e0266086
SARS-CoV-2 antibody tests have been marketed to diagnose previous SARS-CoV-2 infection and as a test of immune status. There is a lack of evidence on the performance and clinical utility of these tests. We aimed to carry out an evaluation of 14 point of care (POC) SARS-CoV-2 antibody tests. Serum from participants with previous RT-PCR (real-time polymerase chain reaction) confirmed SARS-CoV-2 infection and pre-pandemic serum controls were used to determine specificity and sensitivity of each POC device. Changes in sensitivity with increasing time from infection were determined on a cohort of study participants. Corresponding neutralising antibody status was measured to establish whether the detection of antibodies by the POC device correlated with immune status. Paired capillary and serum samples were collected to ascertain whether POC devices performed comparably on capillary samples. Sensitivity and specificity varied between the POC devices and in general did not meet the manufacturers' reported performance characteristics, which signifies the importance of independent evaluation of these tests. The sensitivity peaked at >= 20 days following onset of symptoms, however sensitivity of 3 of the POC devices evaluated at extended time points showed that sensitivity declined with time. This was particularly marked at >140 days post infection. This is relevant if the tests are to be used for sero-prevalence studies. Neutralising antibody data showed that positive antibody results on POC devices did not necessarily confer high neutralising antibody titres, and that these POC devices cannot be used to determine immune status to the SARS-CoV-2 virus. Comparison of paired serum and capillary results showed that there was a decline in sensitivity using capillary blood. This has implications in the utility of the tests as they are designed to be used on capillary blood by the general population.
Xue GA, Braczyk K, Goncalves-Carneiro D, Dawidziak DM, Sanchez K, Ong H, Wan YP, Zadrozny KK, Ganser-Pornillos BK, Bieniasz PD, Pornillos O
Show All Authors

Poly(ADP-ribose) potentiates ZAP antiviral activity

PLOS PATHOGENS 2022 FEB; 18(2):? Article e1009202
Zinc-finger antiviral protein (ZAP), also known as poly(ADP-ribose) polymerase 13 (PARP13), is an antiviral factor that selectively targets viral RNA for degradation. ZAP is active against both DNA and RNA viruses, including important human pathogens such as hepatitis B virus and type 1 human immunodeficiency virus (HIV-1). ZAP selectively binds CpG dinucleotides through its N-terminal RNA-binding domain, which consists of four zinc fingers. ZAP also contains a central region that consists of a fifth zinc finger and two WWE domains. Through structural and biochemical studies, we found that the fifth zinc finger and tandem WWEs of ZAP combine into a single integrated domain that binds to poly(ADP-ribose) (PAR), a cellular polynucleotide. PAR binding is mediated by the second WWE module of ZAP and likely involves specific recognition of an adenosine diphosphate-containing unit of PAR. Mutation of the PAR binding site in ZAP abrogates the interaction in vitro and diminishes ZAP activity against a CpG-rich HIV-1 reporter virus and murine leukemia virus. In cells, PAR facilitates formation of non-membranous sub-cellular compartments such as DNA repair foci, spindle poles and cytosolic RNA stress granules. Our results suggest that ZAP-mediated viral mRNA degradation is facilitated by PAR, and provides a biophysical rationale for the reported association of ZAP with RNA stress granules. Author summary Zinc-finger antiviral protein (ZAP), also known as poly(ADP-ribose) polymerase 13 (PARP13), functions as a host defense mechanism against viruses, including important human pathogens such as hepatitis B virus and type 1 human immunodeficiency virus (HIV-1). ZAP recognizes and binds viral RNA by virtue of their nucleotide composition and directs selective degradation of these viral RNA. Here, we report the X-ray crystal structures of ZAP's central domain, which we found to bind poly(ADP-ribose) (PAR), a cellular polynucleotide. In cells, PAR is associated with macromolecular assemblages that are implicated in virus inhibition and antiviral signaling. We confirm through biochemical experiments that ZAP indeed binds PAR, both in vitro and in cells. However, the PAR-binding activity of ZAP is not essential to its antiviral function. Instead, we find that PAR binding is an ancillary activity that contributes to the potency of ZAP-mediated virus inhibition.
Wang E, Mi XL, Thompson MC, Montoya S, Notti RQ, Afaghani J, Durham BH, Penson A, Witkowski MT, Lu SX, Bourcier J, Hogg SJ, Erickson C, Cui D, Cho HN, Singer M, Totiger TM, Chaudhry S, Geyer M, Alencar A, Linley AJ, Palomba ML, Coombs CC, Park JH, Zelenetz A, Roeker L, Rosendahl M, Tsai DE, Ebata K, Brandhuber B, Hyman DM, Aifantis I, Mato A, Taylor J, Abdel-Wahab O
Show All Authors

Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors

NEW ENGLAND JOURNAL OF MEDICINE 2022 FEB 24; 386(8):735-743
BACKGROUND Covalent (irreversible) Bruton's tyrosine kinase (BTK) inhibitors have transformed the treatment of multiple B-cell cancers, especially chronic lymphocytic leukemia (CLL). However, resistance can arise through multiple mechanisms, including acquired mutations in BTK at residue C481, the binding site of covalent BTK inhibitors. Noncovalent (reversible) BTK inhibitors overcome this mechanism and other sources of resistance, but the mechanisms of resistance to these therapies are currently not well understood. METHODS We performed genomic analyses of pretreatment specimens as well as specimens obtained at the time of disease progression from patients with CLL who had been treated with the noncovalent BTK inhibitor pirtobrutinib. Structural modeling, BTK-binding assays, and cell-based assays were conducted to study mutations that confer resistance to noncovalent BTK inhibitors. RESULTS Among 55 treated patients, we identified 9 patients with relapsed or refractory CLL and acquired mechanisms of genetic resistance to pirtobrutinib. We found mutations (V416L, A428D, M437R, T474I, and L528W) that were clustered in the kinase domain of BTK and that conferred resistance to both noncovalent BTK inhibitors and certain covalent BTK inhibitors. Mutations in BTK or phospholipase C gamma 2 (PLC gamma 2), a signaling molecule and downstream substrate of BTK, were found in all 9 patients. Transcriptional activation reflecting B-cell-receptor signaling persisted despite continued therapy with noncovalent BTK inhibitors. CONCLUSIONS Resistance to noncovalent BTK inhibitors arose through on-target BTK mutations and downstream PLC gamma 2 mutations that allowed escape from BTK inhibition. A proportion of these mutations also conferred resistance across clinically approved covalent BTK inhibitors. These data suggested new mechanisms of genomic escape from established covalent and novel noncovalent BTK inhibitors. (Funded by the American Society of Hematology and others.) Mechanisms of Resistance to Noncovalent BTK Inhibitors In nine patients with chronic lymphocytic leukemia that responded to the noncovalent BTK inhibitor pirtobrutinib and then developed resistance, analysis revealed a number of new mutations in the BTK kinase domain and occasional mutations in downstream PLC gamma 2. Despite the inactivity of BTK, alternative pathways of B-cell-receptor signaling were evident.
Fregoso FE, van Eeuwen T, Simanov G, Rebowski G, Boczkowska M, Zimmet A, Gautreau AM, Dominguez R
Show All Authors

Molecular mechanism of Arp2/3 complex inhibition by Arpin

NATURE COMMUNICATIONS 2022 FEB 2; 13(1):? Article 628
The Arp2/3 complex inhibitor Arpin controls cell migration by interrupting a feedback loop involving Rac-WAVE-Arp2/3 complex Here, the authors use structural, biochemical, and cellular studies to reveal Arpin's mechanism of inhibition. Positive feedback loops involving signaling and actin assembly factors mediate the formation and remodeling of branched actin networks in processes ranging from cell and organelle motility to mechanosensation. The Arp2/3 complex inhibitor Arpin controls the directional persistence of cell migration by interrupting a feedback loop involving Rac-WAVE-Arp2/3 complex, but Arpin's mechanism of inhibition is unknown. Here, we describe the cryo-EM structure of Arpin bound to Arp2/3 complex at 3.24-angstrom resolution. Unexpectedly, Arpin binds Arp2/3 complex similarly to WASP-family nucleation-promoting factors (NPFs) that activate the complex. However, whereas NPFs bind to two sites on Arp2/3 complex, on Arp2-ArpC1 and Arp3, Arpin only binds to the site on Arp3. Like NPFs, Arpin has a C-helix that binds at the barbed end of Arp3. Mutagenesis studies in vitro and in cells reveal how sequence differences within the C-helix define the molecular basis for inhibition by Arpin vs. activation by NPFs.